Current Vaccine Shortages & Delays
Last Updated May 15, 2017
This web page contains the latest national information about vaccine supplies and provides guidance to healthcare providers who are facing vaccine shortages or delays.
*Note: Only those vaccines included on the recommended childhood and adolescent immunization schedule are included in this update.
Vaccines are listed in order used for the Childhood and Adolescent Immunization Schedule.
National Vaccine Supply Shortages
|Vaccine||Shortage||Temporary Change From Routine Recommendation|
|Diphtheria, Tetanus, & Pertussis (DTaP and Tdap)||No|
|Haemophilus influenzae type B (Hib)||No|
|Hepatitis B||See note 1|
|Human Papillomavirus (HPV)||No|
|Inactivated Polio (IPV)||No|
|Influenza||No||See current information about influenza|
|Measles, Mumps, & Rubella (MMR)||See note 2||See Q&As about monovalent M-M-R vaccines Oct 2009|
|Meningococcal Conjugated (MCV4)||No|
|Pneumococcal Conjugated (PCV)||No|
|Pneumococcal Polysaccharide (PPV)||No|
|Serogroup B Meningococcal (MenB)||No|
|Td||See note 3|
Note1: Merck is not currently distributing its adult Hepatitis B vaccine and does not expect to be distributing vaccine through the remainder of 2017. Merck’s supply of pediatric Hepatitis B vaccine and the dialysis formulation of Hepatitis B vaccine are not affected. GSK has sufficient supplies of adult Hep B vaccine to address the anticipated gap in Merck’s adult Hepatitis B vaccine supply during this period; however, preferences for a specific presentation (i.e., vial versus syringe) may not be met consistently during this time. Updated May 2017
Note2: Based on input from the ACIP, professional societies, scientific leaders, and customers on October 26, 2009 Merck announced the company has decided not to resume production of ATTENUVAX® (Measles Virus Vaccine Live), MUMPSVAX® (Mumps Virus Vaccine Live), and MERUVAX®II (Rubella Virus Vaccine Live). This science-based decision will support vaccination of the largest group of appropriate individuals. Updated Jan 2010
Note3: Tenivac ® vaccine (Tetanus and Diphtheria Toxoids Adsorbed) is temporarily unavailable. It is anticipated that the product will become available in the second half of 2017. Grifols, who markets and distributes another US-licensed Td vaccine manufactured by MassBiologics and with labeled indications for the same use as Tenivac ®, has indicated that they have sufficient supply available to address the historical demand for Td vaccine during this time period. Updated Nov 2016
In the United States shortages of many vaccines in the recommended childhood immunization schedule occurred in the past. Some of these shortages were widespread while others were localized. Reasons for these shortages were multi-factorial and included companies leaving the vaccine market, manufacturing or production problems, and insufficient stockpiles. Consequently, some shortages were only specific to one manufacturer.
Shortages of several of these vaccines necessitated temporary changes in recommendations for their use. During that period, summary information about the shortages including projected duration and recommendations for temporary changes in the childhood immunization schedule were provided.
- Questions including those dealing with changes in child care and school requirements necessitated by vaccine supply problems when they occur can be answered by State Health Department immunization programs.
- General immunization questions can be answered by
The CDC Contact Center at 1-800-CDC-INFO
(1-800-232-4636) English and Español
This vaccines shortages page is updated as needed. If you wish to be notified when it is updated, please use enter your email on this page in the box labeled “Get Email Updates”.
The FDA’s web page on Biological Product Shortages provides additional information regarding regulatory issues related to vaccine supply.
Those acronyms and abbrevations not already spelled out above include
- AAFP – American Academy of Family Physicians
- AAP – American Academy of Pediatrics
- ACIP – Advisory Committee on Immunization Practices
- CDC – Centers for Disease Control and Prevention
- FDA – Food and Drug Administration
- GAO – United States General Accounting Office
- GSK – GlaxoSmithKline
- MMRV – Measles, Mumps, Rubella, and Varicella combination vaccine
- MMWR – Morbidity and Mortality Weekly Report
- NCIRD – National Center for Immunization and Respiratory Diseases
- TTY – teletypewriter
- Other acronyms
- Shortages of travel-related vaccines
- Status of Recently Submitted, Licensed, and Recommended Vaccines & Biologics
Red Book® Online
- Influenza Vaccination Recommendations
- Childhood & Adolescent Immunization Schedules
- Adult Immunization Schedule
- Standards for Immunization Practices for children & adolescents and adults [7 pages]
- Page last reviewed: May 16, 2013
- Page last updated: May 15, 2017
- Content source: